[Thrombolysis or angioplasty in acute heart infarct?].
PTCA (percutaneous transluminal coronary angioplasty) has proved to be safe and effective treatment for myocardial infarction which, as compared with thrombolytic treatment, yields more complete revascularisation, better coronary blood flow, reduced mortality, lower relapse rates, and shorter treatment times. There are strong indications that in the near future PTCA will also be accorded a prominent place in the treatment of infarction in the Nordic countries. This will entail changes in the structure of myocardial infarction care.